miR-100 maintains phenotype of tumor-associated macrophages by targeting mTOR to promote tumor metastasis via Stat5a/IL-1ra pathway in mouse breast cancer.

Wang, Wei; Liu, Yan; Guo, Jian; He, Huiwen; Mi, Xue; Chen, Chong; Xie, Junling; Wang, Shengnan; Wu, Peng; Cao, Fengqi; Bai, Lipeng; Si, Qin; Xiang, Rong; Luo, Yunping

Wang, Wei; Liu, Yan; Guo, Jian; He, Huiwen; Mi, Xue; Chen, Chong; Xie, Junling; Wang, Shengnan; Wu, Peng; Cao, Fengqi; Bai, Lipeng; Si, Qin; Xiang, Rong; Luo, Yunping.

Afiliación

Wang W; Department of Immunology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, 100005, Beijing, China.
Liu Y; Collaborative Innovation Center for Biotherapy, School of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, 100005, Beijing, China.
Guo J; Department of Immunology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, 100005, Beijing, China.
He H; Collaborative Innovation Center for Biotherapy, School of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, 100005, Beijing, China.
Mi X; Department of Immunology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, 100005, Beijing, China.
Chen C; Collaborative Innovation Center for Biotherapy, School of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, 100005, Beijing, China.
Xie J; Department of Immunology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, 100005, Beijing, China.
Wang S; Collaborative Innovation Center for Biotherapy, School of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, 100005, Beijing, China.
Wu P; Department of Immunology, Medical School of Nankai University, 300071, Tianjin, China.
Cao F; Department of Immunology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, 100005, Beijing, China.
Bai L; Collaborative Innovation Center for Biotherapy, School of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, 100005, Beijing, China.
Si Q; Department of Immunology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, 100005, Beijing, China.
Xiang R; Collaborative Innovation Center for Biotherapy, School of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, 100005, Beijing, China.
Luo Y; Department of Immunology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, 100005, Beijing, China.

Oncogenesis ; 7(12): 97, 2018 Dec 19.

Article en En | MEDLINE | ID: mdl-30563983

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Oncogenesis Año: 2018 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google